New device to fix a leaky heart valve without surgery
Part of Heart & circulation clinical trials.
This trial is testing a new device to fix a leaky tricuspid valve without open-heart surgery. The device is placed through a tube in a vein, and it may help reduce symptoms like shortness of breath and swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have severe tricuspid regurgitation (a leaky heart valve) that causes symptoms like shortness of breath or swelling.
- Your heart valve shape and size must be suitable for this device, which the study team will check with imaging tests.
- You must be willing to come back to the study site for follow-up visits after the procedure.
- You must not have had prior valve surgery or an artificial heart valve, and no heart procedures within 30 days before or after the study procedure.
- You must not have serious heart, lung, kidney, or liver problems that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study tests a new device to fix a leaking tricuspid valve (the valve that helps blood flow from the heart to the lungs) without open-heart surgery. It is for people with severe leaking that causes symptoms like shortness of breath or tiredness, and who are not good candidates for surgery.
This trial tests the DragonFly-T system to improve symptoms and heart function in people with severe tricuspid regurgitation (a leaky heart valve) using a catheter-based repair. It may help reduce valve leak–related symptoms when standard medication isn’t enough and surgery risk is higher.
Hear when a new Symptomatic Severe Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.